Alzheimer's Disease News and Research

RSS
Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.
The First International Congress on Antioxidant Methods

The First International Congress on Antioxidant Methods

Neurobiologists pinpoint region of the brain responsible for storing distant memories

Neurobiologists pinpoint region of the brain responsible for storing distant memories

Research into Chinese herbal medicine Qian Ceng Ta may help Alzheimer’s

Research into Chinese herbal medicine Qian Ceng Ta may help Alzheimer’s

SPECT imaging may lead to early diagnosis of Alzheimer's

SPECT imaging may lead to early diagnosis of Alzheimer's

New hope for advances in treatment methods for AIDS, Alzheimer's and age-related blindness

New hope for advances in treatment methods for AIDS, Alzheimer's and age-related blindness

$9 billion cost of depression in senior citizens

$9 billion cost of depression in senior citizens

Counseling eases the depression of people caring for a loved one with the devastating brain disease

Counseling eases the depression of people caring for a loved one with the devastating brain disease

First imaging-based diagnostic test for living Alzheimer’s

First imaging-based diagnostic test for living Alzheimer’s

Gene therapy may delay Alzheimer progression

Gene therapy may delay Alzheimer progression

Stroke survivors have twice the risk of dementia compared to stroke-free men and women of the same age

Stroke survivors have twice the risk of dementia compared to stroke-free men and women of the same age

A burst of brain energy depends more on a unique molecular cycle than on blood flow variation

A burst of brain energy depends more on a unique molecular cycle than on blood flow variation

Greater severity of depressive symptoms correlates with increased risk of stroke among whites

Greater severity of depressive symptoms correlates with increased risk of stroke among whites

PET imaging has recently been shown to aid in the diagnosis of particular neurological syndromes associated with cancer

PET imaging has recently been shown to aid in the diagnosis of particular neurological syndromes associated with cancer

A popular supplement, coenzyme Q10 (CoQ10), may help prevent migraine

A popular supplement, coenzyme Q10 (CoQ10), may help prevent migraine

McMaster’s is helping raise awareness of the importance of regular blood pressure monitoring.

McMaster’s is helping raise awareness of the importance of regular blood pressure monitoring.

Results look promising in Alzheimer’s gene therapy trial

Results look promising in Alzheimer’s gene therapy trial

Prana Biotechnology gets US$20 million funding for Alzheimer’s treatment research

Prana Biotechnology gets US$20 million funding for Alzheimer’s treatment research

Blood pressure drug helps delay ischemic brain damage in stroke patients

Blood pressure drug helps delay ischemic brain damage in stroke patients

Apolipoprotein E (APOE) gene may increase the risk of Parkinson’s disease

Apolipoprotein E (APOE) gene may increase the risk of Parkinson’s disease

Improvement of Parkinson’s disease symptoms when neurorestorative molecule pumped to the center of the brain

Improvement of Parkinson’s disease symptoms when neurorestorative molecule pumped to the center of the brain

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.